Magnitude of the benefit of progression-free survival as a potential surrogate marker in phase 3 trials assessing targeted agents in molecularly selected patients with advanced non... von Hotta, Katsuyuki, Kato, Yuka, Leighl, Natasha, Takigawa, Nagio, Gaafar, Rabab Mohamed, Kayatani, Hiroe, Hirata, Taizo, Ohashi, Kadoaki, Kubo, Toshio, Tabata, Masahiro, Tanimoto, Mitsune, Kiura, Katsuyuki

Volltext

Efficacy and Toxicity of Metronomic Chemotherapy in Metastatic Breast Cancer: Egyptian Experience von Hussein, Marwa Mahmoud, Gaafar, Rabab Mohamed, Abdel-Warith, Ahmed Mostafa, Ahmed, Wafaa Abdallah, Ali Allahloubi, Nasr Mohamed, Salem, Salem Eid, Abdel-Salam, Ibrahem Mohamed

Volltext

Independent validation of progression-free survival rate at 9 and 18 weeks (PFSR-18, PFSR-9) as predictor for overall survival (OS) in patients with malignant pleural mesothelioma... von Hasan, Baktiar, Pallis, Athanasios G., Gaafar, Rabab Mohamed, Greillier, Laurent, Van Meerbeeck, Jan P., O'Brien, Mary

Volltext

Toxicity and prediction of survival benefit with metronomic chemotherapy in metastatic breast cancer von Gaafar, Rabab Mohamed, Hussein, Marwa Mahmoud, Allahloubi, Nasr Mohamed Ali, Warith, Ahmed Mohamed Abdel, Abd Allah, Wafaa Ahmed, Salem, Salem Eid, Abdel Salam, Ebrahim Mohamed

Volltext

Platelet counts (PLT) at baseline and on treatment as predictor for progression free survival (PFS) in patients with advanced malignant pleural mesothelioma (MPM): EORTC 08052 stud... von Gaafar, Rabab Mohamed, Popat, Sanjay, Van Meerbeeck, Jan P., Baas, Paul, Fennell, Dean, Pallis, Athanasios G., Hasan, Baktiar, O'Brien, Mary

Volltext

Epidermal growth factor receptor mutation (EGFRMUT) in non-small cell lung cancer (NSCLC) in the Middle East von Jazieh, Abdul Rahman, Jaafar, Hassan Nadim, Mustafa, Rasha, Rasul, Kakil, Zekri, Jamal, Gaafar, Rabab Mohamed, Al Husaini, Hamed Homoud, Azim, Hamdy A., Bamefleh, Hanaa, Gasmelseed, Ahmed

Volltext

Phase II study of bortezomib with cisplatin as first-line treatment of malignant pleural mesothelioma (MPM): EORTC 08052 von O'Brien, Mary, Gaafar, Rabab Mohamed, Popat, Sanjaykumar, Grossi, Francesco, Price, Allan, Talbot, Denis Charles, Cufer, Tanja, Ottensmeier, Christian H.H, Danson, Sarah, Pallis, Athanasios G., Hasan, Baktiar, Van Meerbeeck, Jan P., Baas, Paul

Volltext

Carcinoma of the superior pulmonary sulcus: Results of multidisciplinary treatment von Abdelrahman, Abdelrahman Mohamed, Mourad, Ismael Abdelmonem, Gaafar, Rabab Mohamed, Elhossieny, Hisham Abdelkader

Volltext

Carcinoma of the superior pulmonary sulcus: Results of multidisciplinary treatment: Superior sulcus tumor von Abdelrahman, Abdelrahman Mohamed, Mourad, Ismael Abdelmonem, Gaafar, Rabab Mohamed, Elhossieny, Hisham Abdelkader

Volltext

Primary therapy of early breast cancer: Egyptian view of 2021 St. Gallen consensus von Khaled, Hussein, Nada, Yousry Wasef, Ramadan, Kareem Mohamed, Fekry, Shawkat, Seleam, Mohamed Samy, Gaafar, Rabab, Lotayef, Mohamed

Volltext

Assessing Mutations in Treatment Response-related Genes in Egyptian Patients with Non-small Cell Lung Cancer von Omar, Anan, Bahnassy, Abeer, Gaafer, Rabab, El Desouky, Eman, Medhat, Amina Mohamed

Volltext

Cancer education for medical students in developing countries: Where do we stand and how to improve? von Amgad, Mohamed, Shash, Emad, Gaafar, Rabab

Volltext

Real-World Data on the Prevalence of Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer in the Middle East and North Africa von Jazieh, Abdul Rahman, Gaafar, Rabab, Errihani, Hassan, Jaafar, Hassan, Al Dayel, Fouad, Bahnassy, Abeer A, El Kadi, Hatem, Abdallah, Mohamed Magdy, Zaatari, Ghazi

Volltext

Abstract 1828: Genetic profiling of breast cancer confirms a pivotal role of EGFR pathway in the development of acquired resistance to tamoxifen von Bahnnasy, Abeer A., Malash, Ibrahim, Al-Lahlouby, Nasr, Mansour, Osman, Shaarawy, Sabry, Abdellateif, Mona S., Yousef, Hend, Lotfy, Mai M., Gaafar, Rabab, elsesy, Mohamed, Zekri, Abdel-Rahman N.

Volltext

Contributing factors to the outcome of primary malignant chest wall tumors von Abdel Rahman, Abdel Rahman Mohamed, Rahouma, Mohamed, Gaafar, Rabab, Bahaa, Sherif, Loay, Iman, Kamel, Mohamed, Abdelbaki, Hoda, Yahia, Maha

Volltext

P2.03b-054 Biomarker Predictors in NSCLC von Yahia, Maha, Rahouma, Mohamed, Al Bastawisy, Ahmed, Bahnassy, Abeer, Gaafar, Rabab

Volltext

P2.03b-054 Biomarker Predictors in NSCLC: Topic: Biomarkers von Yahia, Maha, Rahouma, Mohamed, Al Bastawisy, Ahmed, Bahnassy, Abeer, Gaafar, Rabab

Volltext

Primary chemotherapy with low-dose prolonged infusion gemcitabine and cisplatin in patients with bladder cancer: A Phase II trial von Khaled, Hussein, M.D, Emara, Mohamed E., M.D, Gaafar, Rabab M., M.D, Mansour, Osman, M.D, Abdel Warith, Ahmed, M.D, Zaghloul, Mohamed S., M.D, El Malt, Osama, M.D

Volltext

Plasma vascular endothelial growth factor 165 in advanced non-small cell lung cancer von ABDALLAH, AHMED, BELAL, MOHAMED, EL BASTAWISY, AHMED, GAAFAR, RABAB

Volltext

Evaluation of simian virus-40 as a biological prognostic factor in Egyptian patients with malignant pleural mesothelioma von Zekri, Abdel-Rahman N., Bahnassy, Abeer A., Mohamed, Waleed S., Hassan, Nelly, Abdel-Rahman, Abdel-Rahman M., El-Kassem, Fatma Abou, Gaafar, Rabab

Volltext